|
|
 |
Programmme of the conference:
|
|
Tuesday, Oct 5, 2004
|
|
13.00 h
|
Welcome
|
Prof. Dr. Armin Buschauer
|
|
13.10-14.40 h
|
Synthesis, structure, biologic and biomedical investigations of peptides made of homologated proteinogenic amino acids
|
Prof. Dr. Dieter Seebach,
ETH Zürich
|
|
15.15-16.15 h
|
Synthesis, structure, and biological investigations of peptides made of cyclic β-, γ- and δ-amino acids
|
Prof. Dr. Oliver Reiser,
University of Regensburg
|
|
16.15-17.15 h
|
The quest for new drugs: Strategies for Lead Finding and Lead Optimization utilizing experimental and computational approaches
|
Dr. Ulrich Stilz,
Aventis Pharma AG, Frankfurt
|
|
Coffee break
|
|
|
|
17.45-18.45 h
|
Combinatorial chemistry - Diversity driven versus targeted libraries
|
Dr. Peter Ettmayer,
Novartis Pharma, Vienna
|
|
18.45-20.30 h
|
Poster session / Beer and bretzel
|
|
|
|
Wednesday, Oct 6, 2004
|
|
08.30-09.30 h
|
From genome sequences to validated targets, to lead compounds: The impact of structural biology to the drug discovery process
|
Prof. Dr. Martin Schneider,
Schering AG, Berlin
|
|
09.30-10.30 h
|
Enzymatic, fluorometric and crystallographic analysis of adenylyl cyclase
|
Prof. Dr. Roland Seifert,
University of Kansas, Lawrence
|
|
Coffee break
|
|
|
|
11.00-12.00 h
|
Chemogenomics
|
Prof. Dr. Hugo Kubinyi,
University of Heidelberg
|
|
Lunch
|
|
|
|
13.30-14.30 h
|
The concept of bioisosterism in medicinal chemistry
|
Prof. Dr. Peter Gmeiner,
University of Erlangen
|
|
14.30-15.30 h
|
Artifical neuronal networks for identification and optimisation of lead compounds
|
Prof. Dr. Gerhard Ecker,
University of Vienna
|
|
Coffee break
|
|
|
|
16.00-17.00 h
|
3D QSAR methods in drug design
|
Prof. Dr. Wolfgang Sippl,
University of Halle
|
|
17.00-18.00 h
|
Docking and scoring in structure-based drug design
|
Dr. Christoph Sotriffer,
University of Marburg
|
|
18.10-19.10 h
|
Water, Coal and Creativity: Let's prepare for a Barbecue
|
Dr. Eric Haaksma,
Boehringer Ingelheim, Vienna
|
|
19.00 h
|
Barbecue
|
|
|
Thursday, Oct 7, 2004
|
|
|
|
|
